Yupeng Li

2.6k total citations · 1 hit paper
77 papers, 1.8k citations indexed

About

Yupeng Li is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Yupeng Li has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 14 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Yupeng Li's work include Peptidase Inhibition and Analysis (6 papers), Immunotherapy and Immune Responses (6 papers) and Synthesis and Biological Evaluation (5 papers). Yupeng Li is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Immunotherapy and Immune Responses (6 papers) and Synthesis and Biological Evaluation (5 papers). Yupeng Li collaborates with scholars based in China, United States and Canada. Yupeng Li's co-authors include Stephen S. Hecht, Janardhan Banothu, Xiaomei Ren, Ke Ding, Xiaoyun Lu, Ramesh Gondru, Sunil A. David, Bruno G. De Geest, Bart N. Lambrecht and Kim Deswarte and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Yupeng Li

72 papers receiving 1.8k citations

Hit Papers

Carcinogenic components o... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yupeng Li China 23 832 330 320 287 181 77 1.8k
Lih‐Wen Deng Singapore 30 980 1.2× 182 0.6× 276 0.9× 247 0.9× 212 1.2× 52 2.3k
Jan Hraběta Czechia 23 1.6k 2.0× 606 1.8× 193 0.6× 134 0.5× 138 0.8× 53 2.5k
Lin Yang China 28 1.6k 1.9× 340 1.0× 155 0.5× 145 0.5× 338 1.9× 96 3.0k
Lutz Müller Germany 23 920 1.1× 491 1.5× 451 1.4× 130 0.5× 92 0.5× 67 2.2k
Marilisa Leone Italy 27 1.9k 2.3× 418 1.3× 335 1.0× 207 0.7× 73 0.4× 101 2.7k
Darrell Sleep United Kingdom 21 1.4k 1.6× 403 1.2× 99 0.3× 152 0.5× 181 1.0× 25 2.1k
Hyo Jin Kang South Korea 32 1.7k 2.1× 476 1.4× 215 0.7× 175 0.6× 206 1.1× 103 2.9k
Wenjing Wang China 15 927 1.1× 350 1.1× 247 0.8× 137 0.5× 176 1.0× 29 1.6k
Yun Deng China 29 856 1.0× 191 0.6× 331 1.0× 432 1.5× 283 1.6× 123 2.4k
Guan‐Jun Yang China 25 980 1.2× 318 1.0× 197 0.6× 212 0.7× 162 0.9× 83 1.8k

Countries citing papers authored by Yupeng Li

Since Specialization
Citations

This map shows the geographic impact of Yupeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yupeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yupeng Li more than expected).

Fields of papers citing papers by Yupeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yupeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yupeng Li. The network helps show where Yupeng Li may publish in the future.

Co-authorship network of co-authors of Yupeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yupeng Li. A scholar is included among the top collaborators of Yupeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yupeng Li. Yupeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ding, Ke, Yupeng Li, Yang Zhou, & Weixue Huang. (2025). Chemical Adaptation in Drug Discovery: The Medicinal Chemistry Journey of Olverembatinib and Limertinib in Overcoming Kinase Drug Resistance. Accounts of Chemical Research. 58(20). 3195–3209.
3.
Guo, Zhenhuan, Xiaohua Wang, Yupeng Li, et al.. (2025). Evaluation of the therapeutic effect of pomegranate peel ginger ultrafine powder on chronic enteritis in mice by regulating intestinal microbiota. Frontiers in Immunology. 16. 1563225–1563225.
4.
Wei, Yubo, Xin Wang, Ting Wu, et al.. (2024). Sustainable di-functional stimuli-responsive imprinted nanozymes for reversible colorimetric sensing of tetracycline. Sensors and Actuators B Chemical. 423. 136800–136800. 12 indexed citations
5.
Grace, Christy R., Yupeng Li, Carlos C. Rodríguez, et al.. (2024). The carboxy terminus causes interfacial assembly of oleate hydratase on a membrane bilayer. Journal of Biological Chemistry. 300(2). 105627–105627. 8 indexed citations
6.
Michailidou, Georgia, et al.. (2024). A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine. International Journal of Molecular Sciences. 25(2). 913–913. 4 indexed citations
7.
Kallingal, Anoop, Natalia Maciejewska, Yupeng Li, et al.. (2024). Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines. New Journal of Chemistry. 48(18). 8038–8054. 7 indexed citations
8.
Bai, Zhaoshi, Yupeng Li, Yuejiao Zhong, et al.. (2024). Inhibiting autophagy enhanced mitotic catastrophe-mediated anticancer immune responses by regulating the cGAS-STING pathway. Cancer Letters. 586. 216695–216695. 6 indexed citations
9.
Zhou, Chuan, Zisheng Fan, Zhiming Ge, et al.. (2024). Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D. Journal of Medicinal Chemistry. 67(2). 1147–1167. 21 indexed citations
11.
Wang, Qingwei, Xiaofei Guo, Dawei Yao, et al.. (2023). Insights into Transcriptomic Differences in Ovaries between Lambs and Adult Sheep after Superovulation Treatment. Animals. 13(4). 665–665. 2 indexed citations
13.
Li, Yupeng, Xiaoyi Zhu, Yao He, et al.. (2023). Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction. Seminars in Cancer Biology. 91. 50–69. 31 indexed citations
15.
Li, Yupeng & Stephen S. Hecht. (2022). Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed. International Journal of Molecular Sciences. 23(9). 4559–4559. 125 indexed citations
16.
Li, Yupeng, et al.. (2021). Preparing Membrane Proteins for Simulation Using CHARMM-GUI. Methods in molecular biology. 2302. 237–251. 19 indexed citations
17.
Zhang, Zhang, Yupeng Li, Minhao Huang, et al.. (2020). Design and Optimization of 3′-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors. ACS Medicinal Chemistry Letters. 11(3). 379–384. 17 indexed citations
18.
Zhang, Jian‐Guo, et al.. (2019). [Effect of siRNA-Interfering β-Catenin Expression on MDR of Human Multiple Myeloma Cell Line].. PubMed. 27(2). 477–481. 1 indexed citations
19.
Yoo, Euna, Alex C. D. Salyer, Yupeng Li, et al.. (2018). Hyaluronic Acid Conjugates of TLR7/8 Agonists for Targeted Delivery to Secondary Lymphoid Tissue. Bioconjugate Chemistry. 29(8). 2741–2754. 24 indexed citations
20.
Chen, Yegao, et al.. (2008). 1,4,5-Trihydroxy-7-methoxy-9H-fluoren-9-one, a new cytotoxic compound from Dendrobium chrysotoxum. Food Chemistry. 108(3). 973–976. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026